Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EPRXF · as of Jun 9, 2026
Key Statistics
Explore Eupraxia Pharmaceuticals Inc. Data
eprxf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
eprxf competitorsEPRXF
AAPGV
ADOIF
AMEUF
CNVCF
ETXPFStock Performance
Full HistoryAbout Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. operates as a clinical-stage biotechnology firm, focusing its efforts on the discovery, advancement, and commercialization of innovative technologies within the biotech l…
what is eupraxia pharmaceuticals inc. · eprxf stock overview · eupraxia pharmaceuticals inc. company profile · who is eupraxia pharmaceuticals inc. ceo · eprxf OTC · eupraxia pharmaceuticals inc. headquarters · eupraxia pharmaceuticals inc. business segments
About Stock Overview & Key Data
Eupraxia Pharmaceuticals Inc. (EPRXF) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 3, 2021. As of the latest trading session, EPRXF stock price is $3.04, with a market capitalization of $108.3M. The stock has returned -31.99% over the past 12 months and -26.92% year-to-date.
In fiscal year 2023, Eupraxia Pharmaceuticals Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eupraxia Pharmaceuticals Inc. (EPRXF) stock price is $3.04. The stock is traded on OTC under the ticker symbol EPRXF. The 52-week range is $2.93 – $6.78.